Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phase I clinical study on 99mTc-MIBI].

A Kubo1, K Nakamura, T Sanmiya

  • 1Department of Radiology, Keio University Hospital, Tokyo.

Kaku Igaku. the Japanese Journal of Nuclear Medicine
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the Rash Appearance to Distinguish Cholinergic Urticaria Subtypes: A Retrospective Cohort Study.

American journal of clinical dermatology·2025
Same author

Improvement of redness and hyperkeratosis in a case of Nagashima-type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.

Science immunology·2021
Same author

Linear and disseminated porokeratosis in one family showing identical and independent second hits in MVD among skin lesions, respectively: a proof-of-concept study.

The British journal of dermatology·2021
Same author

A case of type 1 segmental Darier disease showing widespread Blaschkoid skin lesions with p.P160L mutation in ATP2A2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

An adult case of X-linked chronic granulomatous disease with skin ulcer on the nose and internal canthus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same journal

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[Prognostic Value of Myocardial Flow Reserve Derived from <sup>13</sup>N-ammonia PET in Patients with Ischemic Heart Disease in Japan].

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[The 47th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 50th Survey in 2024)].

Kaku igaku. The Japanese journal of nuclear medicine·2026
Same journal

[Special Program Abstracts].

Kaku igaku. The Japanese journal of nuclear medicine·2025
Same journal

[Joint Program Abstracts].

Kaku igaku. The Japanese journal of nuclear medicine·2025
See all related articles

Technetium-99m-hexakis 2-methoxy isobutylisonitrile (99mTc-MIBI) is a safe and effective agent for myocardial perfusion imaging. This phase I study found it well-tolerated and capable of producing high-quality cardiac images.

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Development
  • Cardiovascular Imaging

Background:

  • Myocardial perfusion imaging is crucial for diagnosing cardiac conditions.
  • There is a need for reliable and safe radiotracers for assessing heart function.

Purpose of the Study:

  • To evaluate the safety, dosimetry, and efficacy of 99mTc-MIBI as a myocardial perfusion imaging agent in a phase I clinical study.

Main Methods:

  • A phase I clinical trial involving 6 healthy volunteers.
  • Administration of 99mTc-MIBI and monitoring of vital signs and laboratory parameters.
  • Dosimetry calculations and assessment of cardiac uptake and retention using planar and SPECT imaging.

Main Results:

  • 99mTc-MIBI was well-tolerated with only transient metallic taste reported in some volunteers.

Related Experiment Videos

  • Dosimetry was within acceptable limits, with the highest dose to the lower large intestine.
  • Rapid blood clearance and significant heart accumulation were observed, with sustained retention.
  • High-quality myocardial planar and SPECT images were acquired, demonstrating good heart-to-lung and heart-to-liver ratios.

    • Conclusions:

    • 99mTc-MIBI is a safe and effective radiopharmaceutical for myocardial perfusion imaging.
    • The agent demonstrates favorable pharmacokinetic properties and excellent imaging characteristics.
    • 99mTc-MIBI is a promising agent for clinical use in assessing cardiac perfusion.